ADVM is been a lackluster stock to watch for months. Did a quick fib retracement anyway and as you can see, there's not much volatility here. BUT upcoming events this week could bring some focus to the stock.
The company develops gene therapies with a primary focus on its lead candidate, ADVM-022. Last week, the company presented data from its 2-Year OPTIC study...
Adverum Biotechnologies Inc is a US-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company has primarily generated revenue through license, research and collaboration arrangements with its strategic partners. Its lead product...
Adverum Biotechnologies Inc is a US-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company has primarily generated revenue through license, research and collaboration arrangements with its strategic partners. Its lead product...
Adverum Biotechnologies Inc is a US-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company has primarily generated revenue through license, research and collaboration arrangements with its strategic partners. Its lead product...
This will be a good stock to look in the morning at open if you're the type to short stocks.ADVM had some great gains today because they had news released this morning. These penny stocks usually tend to move up for any reason and then drop the next day. On top of that it has also hit some resistance.ADVM will be worth to look at tomorrow morning at open.
Quote:...
30 min chart, possible upward movement this morning as MACD closes in to cross. - Will watch this as market opens.
RSI seems to be perking up and showing signs of upward movement.
